These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34657217)

  • 41. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
    Sardi JC; Gullo FP; Freires IA; Pitangui NS; Segalla MP; Fusco-Almeida AM; Rosalen PL; Regasini LO; Mendes-Giannini MJ
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):387-391. PubMed ID: 27638348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
    Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
    Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro synergy of eugenol on the antifungal effects of voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares.
    Sharifzadeh A; Shokri H
    Equine Vet J; 2021 Jan; 53(1):94-101. PubMed ID: 32298479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals.
    Brito GN; Inocêncio AC; Querido SM; Jorge AO; Koga-Ito CY
    Braz Oral Res; 2011; 25(1):28-33. PubMed ID: 21271179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
    Anil S; Hashem M; Vellappally S; Patil S; Bandara HM; Samaranayake LP
    Mycopathologia; 2014 Oct; 178(3-4):207-15. PubMed ID: 25142726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repurposing of Ribavirin as an Adjunct Therapy against Invasive
    Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
    Sharifzadeh A; Shokri H; Abbaszadeh S
    J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
    Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
    Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin.
    Franiczek R; Gleńsk M; Krzyżanowska B; Włodarczyk M
    Med Mycol; 2015 Nov; 53(8):845-51. PubMed ID: 26092104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Investigation of the activity of the preparation cerbiden against Candida spp].
    Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
    Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
    Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
    Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colonization of voice prostheses by albicans and non-albicans Candida species.
    Bauters TG; Moerman M; Vermeersch H; Nelis HJ
    Laryngoscope; 2002 Apr; 112(4):708-12. PubMed ID: 12152601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
    Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
    J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Phenomenon of increased resistance of yeast-like fungi to nystatin].
    Nierebińska E; Gwieździński Z; Urbanowski S; Pracz M
    Wiad Lek; 1992 Jun; 45(11-12):427-9. PubMed ID: 1441524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.